Browsing by Subject "Antifibrotic"
Now showing items 1-1 of 1
-
(MDPI AG, 2019)New histone deacetylases (HDAC) inhibitors with low toxicity to non-cancerous cells, are a prevalent issue at present because these enzymes are actively involved in fibrotic diseases. We designed and synthesized a novel ...